CSBR Champions Oncology, Inc.
Healthcare$6.01+1.59%ClosedMarket Cap: $83.5M
As of 2026-05-25
Valuation
P/E (TTM)
—
PEG
—
P/B
19.49
P/S
1.44
EV/EBITDA
-105.22
DCF Value
$10.67
FCF Yield
4.6%
Div Yield
0.0%
Margins & Returns
Gross Margin
45.9%
Operating Margin
-3.8%
Net Margin
-3.9%
ROE
-58.0%
ROA
-8.0%
ROIC
-23.2%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q3 null | $16.6M | 46.7% | $-187.0K | $-279.0K | $— | — |
| Q2 null | $15.0M | 51.7% | $185.0K | $299.0K | $— | — |
| Q1 null | $14.0M | 42.9% | $-507.0K | $-466.0K | $— | — |
| Q4 null | $12.4M | 41.1% | $-1.7M | $-1.8M | $— | — |
| FY null | $56.9M | 50.1% | $4.8M | $4.7M | $— | — |
| Q3 null | $17.0M | 61.2% | $4.5M | $4.5M | $— | — |
| Q2 null | $13.5M | 44.9% | $732.0K | $728.0K | $— | — |
| Q1 null | $14.1M | 49.7% | $1.3M | $1.3M | $— | — |
| Q4 null | $14.0M | 48.2% | $-271.0K | $-109.0K | $— | — |
| FY null | $50.2M | 41.4% | $-6.9M | $-7.3M | $— | — |
| Q3 2024 | $12.0M | 34.7% | $-2.6M | $-2.5M | $-0.19 | — |
| Q2 2024 | $11.6M | 42.8% | $-2.0M | $-2.1M | $-0.15 | — |